ContractopenMD
ADVANCE UNIVERSAL INFLUENZA VACCINE - FLU MOSAIC VERSION 2 (FLUMOSV2)
National Institutes of HealthDescription
ADVANCE UNIVERSAL INFLUENZA VACCINE - FLU MOSAIC VERSION 2 (FLUMOSV2) Recipient: LEIDOS BIOMEDICAL RESEARCH INC Award Amount: $141.66M
Requirements
Source: USASpending.gov
Interested in this contract?
Sign up to get match scores, track opportunities, and manage proposals with AI-powered tools.
Contract Details
Value Range
Up to $141,660,000
Deadline
January 28, 2031
Geographic Scope
MD
Status
open
External Links
View Original ListingSee how well this contract matches your organization.
Get Your Match Score